微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 53.39% | -12.09% | -10.52% | 70/157 | 50.55% | 海创药业 | 99.82% | 行业排名> |
| 2025-12-31 | 59.67% | 1.89% | -2.06% | 51/157 | 50.61% | 海创药业 | 98.62% | 行业排名> |
| 2025-09-30 | 60.92% | 4.64% | 1.35% | 49/157 | -2.2% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 60.11% | 5.42% | -1.03% | 52/157 | 14.83% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 60.73% | 13.14% | 3.71% | 46/157 | 31.96% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 58.56% | 4.73% | 0.58% | 51/157 | 51.88% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 58.22% | 4.64% | 2.11% | 56/157 | 22.51% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 57.02% | 14.51% | 6.22% | 62/157 | 33.12% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 53.68% | 17.82% | -4% | 66/157 | 51.76% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 55.92% | 8.32% | 0.5% | 66/157 | 51.61% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 55.64% | 11.79% | 11.74% | 68/157 | 32.47% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 49.79% | -3.25% | 9.29% | 79/157 | 38.42% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 45.56% | -18.14% | -11.74% | 89/157 | 52.97% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 51.62% | 5.07% | 3.73% | 82/157 | 53.83% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 49.77% | 1.38% | -3.29% | 79/157 | 5.64% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 51.46% | 11.53% | -7.53% | 78/157 | 20.99% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 55.66% | 30.1% | 13.28% | 66/157 | 54.39% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 49.13% | 3.98% | 0.08% | 85/157 | 55.2% | 首药控股 | 99.93% | 行业排名> |
| 2021-09-30 | 49.09% | -3.13% | 6.39% | 76/157 | 46.77% | 艾力斯 | 99.41% | 行业排名> |
| 2021-06-30 | 46.14% | -7.69% | 7.86% | 82/157 | 47.23% | 艾力斯 | 98.7% | 行业排名> |
| 2021-03-31 | 42.78% | 2% | -9.46% | 78/157 | 54.13% | 艾力斯 | 99.4% | 行业排名> |
| 2020-12-31 | 47.25% | -7.88% | -6.76% | 85/157 | -148.64% | 首药控股 | 99.94% | 行业排名> |
| 2020-09-30 | 50.68% | 2% | 1.39% | 66/157 | 56.43% | 泽璟制药 | 99.96% | 行业排名> |
| 2020-06-30 | 49.99% | 3.76% | -2.55% | 71/157 | 54.17% | 微芯生物 | 95.14% | 行业排名> |
| 2019-12-31 | 51.3% | 9% | 6.48% | 73/157 | -1242.15% | 多瑞医药 | 95.59% | 行业排名> |
| 2019-06-30 | 48.18% | 2% | 2.38% | 65/157 | 55.21% | 微芯生物 | 95.81% | 行业排名> |
| 2018-12-31 | 47.06% | -3.01% | -3.01% | 76/157 | -211.97% | 微芯生物 | 96.09% | 行业排名> |
| 2017-12-31 | 48.52% | 2% | 2% | 66/157 | 52.55% | 微芯生物 | 96.11% | 行业排名> |